当前位置:
X-MOL 学术
›
Cell. Oncol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Peroxiredoxin 4 suppresses anoikis and augments growth and metastasis of hepatocellular carcinoma cells through the β-catenin/ID2 pathway.
Cellular Oncology ( IF 4.9 ) Pub Date : 2019-06-29 , DOI: 10.1007/s13402-019-00460-0 Wei Wang 1 , Xia-Bo Shen 1 , Da-Bing Huang 1 , Wei Jia 1 , Wen-Bin Liu 2 , Yi-Fu He 1
中文翻译:
Peroxiredoxin 4 通过 β-catenin/ID2 通路抑制失巢凋亡并促进肝细胞癌细胞的生长和转移。
更新日期:2019-06-29
Cellular Oncology ( IF 4.9 ) Pub Date : 2019-06-29 , DOI: 10.1007/s13402-019-00460-0 Wei Wang 1 , Xia-Bo Shen 1 , Da-Bing Huang 1 , Wei Jia 1 , Wen-Bin Liu 2 , Yi-Fu He 1
Affiliation
Purpose
Peroxiredoxin 4 (PRDX4) has been reported to play a dual role in the progression of hepatocellular carcinoma (HCC). As yet, however, the underlying molecular mechanism has not been fully elucidated.Methods
We examined the effects of PRDX4 on the growth and survival of HCC cells in an anchorage-independent microenvironment. The regulation of β-catenin stability and activity by PRDX4 was investigated.Results
We found that PRDX4 depletion reduced, and PRDX4 overexpression increased, both anchorage-dependent and anchorage-independent growth of HCC cells. We also found that PRDX4 depletion caused an overproduction of reactive oxygen species (ROS) in HCC cells, especially under suspension conditions. PRDX4 knockdown predisposed HCC cells to anoikis, whereas PRDX4 overexpression induced resistance to anoikis. Subsequent in vivo studies confirmed that PRDX4 deficiency blocks HCC tumor growth and pulmonary metastasis. Mechanistically, we found that RDX4 reduced β-TrCP-mediated β-catenin ubiquitination and enhanced β-catenin protein stability, consequently leading to activation of β-catenin signaling. Silencing of β-catenin impaired PRDX4-mediated anchorage-independent growth and survival, whereas β-catenin overexpression increased the survival and growth of PRDX4-depleted cells under anchorage-independent conditions. Further investigation revealed that the β-catenin downstream gene ID2 is responsible for the oncogenic activity of PRDX4 in HCC cells, promoting anchorage-independent growth and anoikis resistance.Conclusions
PRDX4 reduces anoikis and promotes tumorigenesis and metastasis of HCC cells through stabilization of the β-catenin protein and upregulation of ID2. Targeting of PRDX4 may represent a promising strategy to block HCC cell growth and metastasis.中文翻译:
Peroxiredoxin 4 通过 β-catenin/ID2 通路抑制失巢凋亡并促进肝细胞癌细胞的生长和转移。